尿道感染最常见的病原菌是大肠杆菌,近年来,产酶菌株增加,医院内50%的菌株对羟氨苄青霉素和氨苄青霉素耐药。同样磺胺/甲氧苄氨嘧啶耐药性也增加。Cefuroximeaxetil是一种新的Cefuroxime的酯,口服后,可迅速从胃肠道吸收,血清和尿液中均可达到较高的浓度。Cefuroxime对酶的稳定性可以用于治疗尿道感染。本研究报告使用Cefuroxime axetif单剂量治疗妇女单纯性 The most common pathogen of urinary tract infection is Escherichia coli, in recent years, enzyme-producing strains increased, 50% of the hospital strains of amoxicillin and ampicillin resistance. Same sulfa / trimethoprim resistance also increased. Cefuroximeaxetil, a new ester of Cefuroxime, is rapidly absorbed from the gastrointestinal tract after oral administration and can reach higher concentrations in serum and urine. Cefuroxime’s stability to enzymes can be used to treat urinary tract infections. This study reports the use of single Cefuroxime axetif treatment of women’s simplex